Author:
Lin Tzu-Yi,Hsieh Yi-Ting,Garg Sunir J.,Chen Lee-Jen,Chen Kuan-Jen,Wu Wei-Chi,Lai Chi-Chun,Hwang Yih-Shiou,Kang Eugene Yu-Chuan
Funder
Chang Gung Memorial Hospital
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Ramulu PY, Do DV, Corcoran KJ, et al. Use of retinal procedures in medicare beneficiaries from 1997 to 2007. Arch Ophthalmol. 2010;128:1335–40.
2. Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina. 2009;29:875–912.
3. Uhr JH, Xu D, Rahimy E, et al. current practice preferences and safety protocols for intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmol Retina. 2019;3:649–55.
4. Solomon SD, Lindsley K, Vedula SS, et al. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014;8:Cd005139.
5. Maloney MH, Payne SR, Herrin J, et al. Risk of systemic adverse events after intravitreal bevacizumab, ranibizumab, and aflibercept in routine clinical practice. Ophthalmol. 2021;128:417–24.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献